Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-18

Clinical Trial Update: A Study of LY900014 in Participants With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study of LY900014 in participants with Type 1 Diabetes Mellitus has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2020-06-18